These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
[_]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3177549
|
(State or Other Jurisdiction of
|
(I.R.S. Employer
|
Incorporation or Organization)
|
Identification No.)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
|
Page
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
July 29,
|
|
July 31,
|
|
July 29,
|
|
July 31,
|
||||||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
1,044,270
|
|
|
$
|
1,016,517
|
|
|
$
|
1,969,147
|
|
|
$
|
1,978,556
|
|
Cost of revenue
|
503,551
|
|
|
491,233
|
|
|
965,064
|
|
|
968,769
|
|
||||
Gross profit
|
540,719
|
|
|
525,284
|
|
|
1,004,083
|
|
|
1,009,787
|
|
||||
Operating expenses
|
|
|
|
|
|
|
|
||||||||
Research and development
|
281,193
|
|
|
247,721
|
|
|
565,095
|
|
|
479,245
|
|
||||
Sales, general and administrative
|
119,903
|
|
|
103,533
|
|
|
226,539
|
|
|
201,650
|
|
||||
Total operating expenses
|
401,096
|
|
|
351,254
|
|
|
791,634
|
|
|
680,895
|
|
||||
Income from operations
|
139,623
|
|
|
174,030
|
|
|
212,449
|
|
|
328,892
|
|
||||
Interest income
|
5,316
|
|
|
5,266
|
|
|
10,514
|
|
|
10,579
|
|
||||
Other income (expense), net
|
269
|
|
|
(1,749
|
)
|
|
(660
|
)
|
|
(5,439
|
)
|
||||
Income before income tax expense
|
145,208
|
|
|
177,547
|
|
|
222,303
|
|
|
334,032
|
|
||||
Income tax expense
|
26,162
|
|
|
25,974
|
|
|
42,820
|
|
|
47,240
|
|
||||
Net income
|
$
|
119,046
|
|
|
$
|
151,573
|
|
|
$
|
179,483
|
|
|
$
|
286,792
|
|
|
|
|
|
|
|
|
|
||||||||
Basic net income per share
|
$
|
0.19
|
|
|
$
|
0.25
|
|
|
$
|
0.29
|
|
|
$
|
0.48
|
|
Shares used in basic per share computation
|
618,996
|
|
|
601,340
|
|
|
617,388
|
|
|
598,077
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Diluted net income per share
|
$
|
0.19
|
|
|
$
|
0.25
|
|
|
$
|
0.29
|
|
|
$
|
0.47
|
|
Shares used in diluted per share computation
|
623,143
|
|
|
613,934
|
|
|
623,397
|
|
|
615,552
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
July 29,
|
|
July 31,
|
|
July 29,
|
|
July 31,
|
||||||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
|
||||||||||||||
Net income
|
$
|
119,046
|
|
|
$
|
151,573
|
|
|
$
|
179,483
|
|
|
$
|
286,792
|
|
Net change in unrealized gains on available-for-sale securities
|
1,111
|
|
|
3,871
|
|
|
1,009
|
|
|
5,079
|
|
||||
Less: reclassification adjustments for net realized gains on available-for-sale securities included in net income
|
(208
|
)
|
|
(320
|
)
|
|
(340
|
)
|
|
(401
|
)
|
||||
Income tax expense related to net unrealized and net realized gains on available-for-sale securities
|
(191
|
)
|
|
(238
|
)
|
|
(124
|
)
|
|
(515
|
)
|
||||
Other comprehensive income, net of tax
|
$
|
712
|
|
|
$
|
3,313
|
|
|
$
|
545
|
|
|
$
|
4,163
|
|
Total comprehensive income
|
$
|
119,758
|
|
|
$
|
154,886
|
|
|
$
|
180,028
|
|
|
$
|
290,955
|
|
|
July 29,
|
|
January 29,
|
||||
|
2012
|
|
2012
|
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
499,618
|
|
|
$
|
667,876
|
|
Marketable securities
|
2,778,482
|
|
|
2,461,700
|
|
||
Accounts receivable, net
|
445,312
|
|
|
336,143
|
|
||
Inventories
|
387,185
|
|
|
340,297
|
|
||
Prepaid expenses and other
|
53,323
|
|
|
49,411
|
|
||
Deferred income taxes
|
49,931
|
|
|
49,931
|
|
||
Total current assets
|
4,213,851
|
|
|
3,905,358
|
|
||
Property and equipment, net
|
574,056
|
|
|
560,072
|
|
||
Goodwill
|
641,030
|
|
|
641,030
|
|
||
Intangible assets, net
|
346,938
|
|
|
326,136
|
|
||
Other assets
|
116,006
|
|
|
120,332
|
|
||
Total assets
|
$
|
5,891,881
|
|
|
$
|
5,552,928
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
417,250
|
|
|
$
|
335,072
|
|
Accrued liabilities and other
|
604,710
|
|
|
594,886
|
|
||
Total current liabilities
|
1,021,960
|
|
|
929,958
|
|
||
Other long-term liabilities
|
396,019
|
|
|
455,807
|
|
||
Capital lease obligations, long-term
|
20,237
|
|
|
21,439
|
|
||
Commitments and contingencies - see Note 12
|
—
|
|
|
—
|
|
||
Stockholders’ equity:
|
|
|
|
||||
Preferred stock
|
—
|
|
|
—
|
|
||
Common stock
|
713
|
|
|
700
|
|
||
Additional paid-in capital
|
3,040,979
|
|
|
2,900,896
|
|
||
Treasury stock, at cost
|
(1,509,087
|
)
|
|
(1,496,904
|
)
|
||
Accumulated other comprehensive income
|
11,159
|
|
|
10,614
|
|
||
Retained earnings
|
2,909,901
|
|
|
2,730,418
|
|
||
Total stockholders' equity
|
4,453,665
|
|
|
4,145,724
|
|
||
Total liabilities and stockholders' equity
|
$
|
5,891,881
|
|
|
$
|
5,552,928
|
|
|
Six Months Ended
|
||||||
|
July 29,
|
|
July 31,
|
||||
|
2012
|
|
2011
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
179,483
|
|
|
$
|
286,792
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
|
|
|
||||
Depreciation and amortization
|
110,686
|
|
|
99,923
|
|
||
Stock-based compensation expense
|
67,824
|
|
|
67,689
|
|
||
Deferred income taxes
|
13,791
|
|
|
20,082
|
|
||
Excess tax benefits from stock-based compensation
|
(18,154
|
)
|
|
(25,021
|
)
|
||
Other
|
32,496
|
|
|
10,695
|
|
||
Changes in operating assets and liabilities, net of effect of acquisition:
|
|
|
|
||||
Accounts receivable
|
(109,218
|
)
|
|
(57,511
|
)
|
||
Inventories
|
(46,834
|
)
|
|
(2,169
|
)
|
||
Prepaid expenses and other current assets
|
(3,912
|
)
|
|
2,255
|
|
||
Other assets
|
494
|
|
|
(992
|
)
|
||
Accounts payable
|
65,646
|
|
|
(8,366
|
)
|
||
Accrued liabilities and other long-term liabilities
|
(100,624
|
)
|
|
(139,156
|
)
|
||
Net cash provided by operating activities
|
191,678
|
|
|
254,221
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of marketable securities
|
(1,247,664
|
)
|
|
(711,674
|
)
|
||
Proceeds from sales and maturities of marketable securities
|
918,856
|
|
|
591,242
|
|
||
Purchases of property and equipment and intangible assets
|
(90,867
|
)
|
|
(54,518
|
)
|
||
Acquisition of businesses, net of cash acquired
|
—
|
|
|
(348,884
|
)
|
||
Other
|
(82
|
)
|
|
(1,890
|
)
|
||
Net cash used in investing activities
|
(419,757
|
)
|
|
(525,724
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from issuance of common stock under employee stock plans
|
42,678
|
|
|
124,785
|
|
||
Payments under capital lease obligations
|
(1,011
|
)
|
|
(731
|
)
|
||
Excess tax benefits from stock-based compensation
|
18,154
|
|
|
25,021
|
|
||
Payment of notes payable assumed from acquisition
|
—
|
|
|
(10,319
|
)
|
||
Net cash provided by financing activities
|
59,821
|
|
|
138,756
|
|
||
Change in cash and cash equivalents
|
(168,258
|
)
|
|
(132,747
|
)
|
||
Cash and cash equivalents at beginning of period
|
667,876
|
|
|
665,361
|
|
||
Cash and cash equivalents at end of period
|
$
|
499,618
|
|
|
$
|
532,614
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid (received) for income taxes, net
|
$
|
(43,149
|
)
|
|
$
|
2,854
|
|
Cash paid for interest on capital lease obligations
|
$
|
1,474
|
|
|
$
|
1,510
|
|
Other non-cash activities:
|
|
|
|
||||
Assets acquired by assuming related liabilities
|
$
|
54,230
|
|
|
$
|
13,673
|
|
Change in unrealized gains from marketable securities
|
$
|
545
|
|
|
$
|
4,163
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
July 29,
2012 |
|
July 31,
2011 |
|
July 29,
2012 |
|
July 31,
2011 |
||||||||
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
Cost of revenue
|
$
|
2,649
|
|
|
$
|
2,748
|
|
|
$
|
5,175
|
|
|
$
|
5,225
|
|
Research and development
|
18,885
|
|
|
21,697
|
|
|
40,092
|
|
|
40,286
|
|
||||
Sales, general and administrative
|
10,721
|
|
|
11,505
|
|
|
22,557
|
|
|
22,178
|
|
||||
Total
|
$
|
32,255
|
|
|
$
|
35,950
|
|
|
$
|
67,824
|
|
|
$
|
67,689
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
July 29,
2012 |
|
July 31,
2011 |
|
July 29,
2012 |
|
July 31,
2011 |
||||
Stock Options
|
(Using a binomial model)
|
||||||||||
Expected life (in years)
|
3.1-4.8
|
|
|
3.6-4.7
|
|
|
3.1-4.8
|
|
|
3.6-5.4
|
|
Risk free interest rate
|
1.5%-1.9%
|
|
|
2.9%-3.2%
|
|
|
1.5%-2.3%
|
|
|
2.9%-3.8%
|
|
Volatility
|
43%-48%
|
|
|
46%-49%
|
|
|
43%-48%
|
|
|
46%-61%
|
|
Dividend yield
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
July 29,
2012 |
|
July 31,
2011 |
|
July 29,
2012 |
|
July 31,
2011 |
||||
Employee Stock Purchase Plan
|
(Using a Black-Scholes model)
|
||||||||||
Expected life (in years)
|
—
|
|
|
—
|
|
|
0.5-2.0
|
|
|
0.5-2.0
|
|
Risk free interest rate
|
—
|
|
|
—
|
|
|
0.1%-0.3%
|
|
|
0.2%-0.7%
|
|
Volatility
|
—
|
|
|
—
|
|
|
44
|
%
|
|
57
|
%
|
Dividend yield
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Options Outstanding
|
|
Weighted Average Exercise Price
|
|||
Stock Options
|
(In thousands)
|
|
(Per share)
|
|||
Balances, January 29, 2012
|
33,329
|
|
|
$
|
14.44
|
|
Granted
|
3,603
|
|
|
$
|
14.14
|
|
Exercised
|
(2,727
|
)
|
|
$
|
9.13
|
|
Cancelled
|
(1,878
|
)
|
|
$
|
16.94
|
|
Balances, July 29, 2012
|
32,327
|
|
|
$
|
14.71
|
|
|
RSUs
Outstanding
|
|
Weighted Average Grant-Date Fair Value
|
|||
Restricted Stock Units
|
(In thousands)
|
|
(Per share)
|
|||
Balances, January 29, 2012
|
13,638
|
|
|
$
|
15.10
|
|
Granted
|
3,974
|
|
|
$
|
14.23
|
|
Vested
|
(2,470
|
)
|
|
$
|
14.14
|
|
Cancelled
|
(364
|
)
|
|
$
|
15.51
|
|
Balances, July 29, 2012
|
14,778
|
|
|
$
|
15.01
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
July 29,
|
|
July 31,
|
|
July 29,
|
|
July 31,
|
||||||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
(In thousands, except per share data)
|
||||||||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
119,046
|
|
|
$
|
151,573
|
|
|
$
|
179,483
|
|
|
$
|
286,792
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Denominator for basic net income per share, weighted average shares
|
618,996
|
|
|
601,340
|
|
|
617,388
|
|
|
598,077
|
|
||||
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Equity awards outstanding
|
4,147
|
|
|
12,594
|
|
|
6,009
|
|
|
17,475
|
|
||||
Denominator for diluted net income per share, weighted average shares
|
623,143
|
|
|
613,934
|
|
|
623,397
|
|
|
615,552
|
|
||||
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic net income per share
|
$
|
0.19
|
|
|
$
|
0.25
|
|
|
$
|
0.29
|
|
|
$
|
0.48
|
|
Diluted net income per share
|
$
|
0.19
|
|
|
$
|
0.25
|
|
|
$
|
0.29
|
|
|
$
|
0.47
|
|
Potentially dilutive securities excluded from income per diluted share because their effect would have been anti-dilutive
|
27,121
|
|
|
13,547
|
|
|
24,882
|
|
|
14,345
|
|
|
July 29, 2012
|
||||||||||||||
|
Amortized
Cost
|
|
Unrealized
Gain
|
|
Unrealized
Loss
|
|
Estimated
Fair Value
|
||||||||
|
(In thousands)
|
||||||||||||||
Debt securities of United States government agencies
|
$
|
788,140
|
|
|
$
|
1,370
|
|
|
$
|
(77
|
)
|
|
$
|
789,433
|
|
Corporate debt securities
|
1,209,149
|
|
|
3,706
|
|
|
(71
|
)
|
|
1,212,784
|
|
||||
Mortgage backed securities issued by United States government-sponsored enterprises
|
176,563
|
|
|
6,121
|
|
|
(54
|
)
|
|
182,630
|
|
||||
Money market funds
|
70,110
|
|
|
—
|
|
|
—
|
|
|
70,110
|
|
||||
Debt securities issued by United States Treasury
|
630,696
|
|
|
1,350
|
|
|
(164
|
)
|
|
631,882
|
|
||||
Total
|
$
|
2,874,658
|
|
|
$
|
12,547
|
|
|
$
|
(366
|
)
|
|
$
|
2,886,839
|
|
Classified as:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents
|
|
|
|
|
|
|
|
|
|
$
|
108,357
|
|
|||
Marketable securities
|
|
|
|
|
|
|
|
|
|
2,778,482
|
|
||||
Total
|
|
|
|
|
|
|
|
|
|
$
|
2,886,839
|
|
|
January 29, 2012
|
||||||||||||||
|
Amortized
Cost
|
|
Unrealized
Gain
|
|
Unrealized
Loss
|
|
Estimated
Fair Value
|
||||||||
|
(In thousands)
|
||||||||||||||
Debt securities of United States government agencies
|
$
|
769,300
|
|
|
$
|
1,605
|
|
|
$
|
(151
|
)
|
|
$
|
770,754
|
|
Corporate debt securities
|
1,114,439
|
|
|
3,268
|
|
|
(260
|
)
|
|
1,117,447
|
|
||||
Mortgage backed securities issued by United States government-sponsored enterprises
|
156,668
|
|
|
4,964
|
|
|
(73
|
)
|
|
161,559
|
|
||||
Money market funds
|
290,732
|
|
|
—
|
|
|
—
|
|
|
290,732
|
|
||||
Debt securities issued by United States Treasury
|
533,616
|
|
|
2,161
|
|
|
(3
|
)
|
|
535,774
|
|
||||
Total
|
$
|
2,864,755
|
|
|
$
|
11,998
|
|
|
$
|
(487
|
)
|
|
$
|
2,876,266
|
|
Classified as:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
|
|
|
|
|
|
$
|
414,566
|
|
||||||
Marketable securities
|
|
|
|
|
|
|
2,461,700
|
|
|||||||
Total
|
|
|
|
|
|
|
$
|
2,876,266
|
|
|
July 29, 2012
|
|
January 29, 2012
|
||||||||||||
|
Amortized
Cost
|
|
Estimated
Fair Value
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
||||||||
|
(In thousands)
|
||||||||||||||
Less than one year
|
$
|
1,201,750
|
|
|
$
|
1,203,585
|
|
|
$
|
1,705,916
|
|
|
$
|
1,708,154
|
|
Due in 1 - 5 years
|
1,481,638
|
|
|
1,487,704
|
|
|
1,047,956
|
|
|
1,053,265
|
|
||||
Mortgage-backed securities issued by government-sponsored enterprises not due at a single maturity date
|
191,270
|
|
|
195,550
|
|
|
110,883
|
|
|
114,847
|
|
||||
Total
|
$
|
2,874,658
|
|
|
$
|
2,886,839
|
|
|
$
|
2,864,755
|
|
|
$
|
2,876,266
|
|
|
Fair Value Measurement at Reporting Date Using
|
||||||||||
|
|
|
Quoted Prices
in Active Markets for Identical Assets
|
|
Significant Other Observable Inputs
|
||||||
|
July 29, 2012
|
|
(Level 1)
|
|
(Level 2)
|
||||||
|
(In thousands)
|
||||||||||
Debt securities issued by United States government agencies (1)
|
$
|
789,433
|
|
|
$
|
—
|
|
|
$
|
789,433
|
|
Debt securities issued by United States Treasury (1)
|
631,882
|
|
|
—
|
|
|
631,882
|
|
|||
Corporate debt securities (2)
|
1,212,784
|
|
|
—
|
|
|
1,212,784
|
|
|||
Mortgage-backed securities issued by government-sponsored entities (1)
|
182,630
|
|
|
—
|
|
|
182,630
|
|
|||
Money market funds (3)
|
70,110
|
|
|
70,110
|
|
|
—
|
|
|||
Total cash equivalents and marketable securities
|
$
|
2,886,839
|
|
|
$
|
70,110
|
|
|
$
|
2,816,729
|
|
(1)
|
Included in Marketable Securities on the Condensed Consolidated Balance Sheet.
|
(2)
|
Includes
$38.2 million
in Cash Equivalents and
$1,174.6 million
in Marketable Securities on the Condensed Consolidated Balance Sheet.
|
(3)
|
Included in Cash Equivalents on the Condensed Consolidated Balance Sheet.
|
|
Fair Market Value
|
|
Straight-Line Amortization Period
|
|||
|
(In thousands)
|
|
(In years)
|
|||
Property and equipment
|
$
|
2,433
|
|
|
1-2
|
|
Trademarks
|
11,310
|
|
|
5
|
|
|
Goodwill
|
85,418
|
|
|
—
|
|
|
Total
|
$
|
99,161
|
|
|
|
|
Cash
|
$
|
3,315
|
|
Accounts receivable
|
13,740
|
|
|
Inventory
|
13,510
|
|
|
Prepaid and other current assets
|
1,972
|
|
|
Deferred tax assets
|
13,036
|
|
|
Property, plant and equipment
|
3,649
|
|
|
Goodwill
|
271,186
|
|
|
Intangible assets
|
97,515
|
|
|
Other assets
|
591
|
|
|
Total assets acquired
|
418,514
|
|
|
|
|
||
Accounts payable
|
(6,026
|
)
|
|
Accrued liabilities
|
(38,735
|
)
|
|
Notes payable
|
(10,319
|
)
|
|
Income taxes payable
|
(4,558
|
)
|
|
Deferred income tax liabilities
|
(6,677
|
)
|
|
Net assets acquired
|
$
|
352,199
|
|
Intangible Assets
|
|
Fair Value
|
|
Weighted-Average
Estimated Useful Lives
|
|||
|
|
(In thousands)
|
|
(In years)
|
|||
Technology
|
|
$
|
58,300
|
|
|
7.4
|
|
In-process technology
|
|
$
|
20,200
|
|
|
indefinite
|
|
Customer relationships
|
|
$
|
18,200
|
|
|
6.8
|
|
|
July 29, 2012
|
|
January 29, 2012
|
||||||||||||||||||||
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
|
Gross
Carrying
Amount
|
|
Accumulated Amortization
|
|
Net Carrying
Amount
|
||||||||||||
|
(In thousands)
|
||||||||||||||||||||||
Acquisition-related intangible assets
|
$
|
172,039
|
|
|
$
|
(87,659
|
)
|
|
$
|
84,380
|
|
|
$
|
172,039
|
|
|
$
|
(79,261
|
)
|
|
$
|
92,778
|
|
Patents and licensed technology
|
406,954
|
|
|
(144,396
|
)
|
|
262,558
|
|
|
352,386
|
|
|
(119,028
|
)
|
|
233,358
|
|
||||||
Total intangible assets
|
$
|
578,993
|
|
|
$
|
(232,055
|
)
|
|
$
|
346,938
|
|
|
$
|
524,425
|
|
|
$
|
(198,289
|
)
|
|
$
|
326,136
|
|
|
July 29,
|
|
January 29,
|
||||
|
2012
|
|
2012
|
||||
Inventories:
|
(In thousands)
|
||||||
Raw materials
|
$
|
87,117
|
|
|
$
|
84,927
|
|
Work in-process
|
82,339
|
|
|
62,934
|
|
||
Finished goods
|
217,729
|
|
|
192,436
|
|
||
Total inventories
|
$
|
387,185
|
|
|
$
|
340,297
|
|
|
July 29,
|
|
January 29,
|
||||
|
2012
|
|
2012
|
||||
Prepaid Expenses and Other:
|
(In thousands)
|
||||||
Prepaid maintenance
|
$
|
18,107
|
|
|
$
|
12,965
|
|
Prepaid insurance
|
3,263
|
|
|
3,502
|
|
||
Prepaid taxes
|
10,069
|
|
|
10,069
|
|
||
Prepaid rent
|
2,635
|
|
|
3,410
|
|
||
Other
|
19,249
|
|
|
19,465
|
|
||
Total prepaid expenses and other
|
$
|
53,323
|
|
|
$
|
49,411
|
|
|
July 29,
|
|
January 29,
|
||||
|
2012
|
|
2012
|
||||
Accrued Liabilities:
|
(In thousands)
|
||||||
Deferred revenue
|
$
|
273,182
|
|
|
$
|
270,649
|
|
Accrued customer programs (1)
|
149,074
|
|
|
143,972
|
|
||
Warranty accrual (2)
|
16,537
|
|
|
18,406
|
|
||
Accrued payroll and related expenses
|
94,350
|
|
|
88,879
|
|
||
Accrued legal settlement (3)
|
30,600
|
|
|
30,600
|
|
||
Taxes payable, short-term
|
10,165
|
|
|
6,941
|
|
||
Other
|
30,802
|
|
|
35,439
|
|
||
Total accrued liabilities and other
|
$
|
604,710
|
|
|
$
|
594,886
|
|
|
July 29,
|
|
January 29,
|
||||
|
2012
|
|
2012
|
||||
Other Long-Term Liabilities:
|
(In thousands)
|
||||||
Deferred income tax liability
|
$
|
143,165
|
|
|
$
|
133,288
|
|
Income taxes payable, long-term
|
108,588
|
|
|
63,007
|
|
||
Asset retirement obligation
|
10,337
|
|
|
10,199
|
|
||
Deferred revenue
|
68,172
|
|
|
200,370
|
|
||
Other long-term liabilities
|
65,757
|
|
|
48,943
|
|
||
Total other long-term liabilities
|
$
|
396,019
|
|
|
$
|
455,807
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
July 29,
|
|
July 31,
|
|
July 29,
|
|
July 31,
|
||||||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
(In thousands)
|
||||||||||||||
Balance at beginning of period (1)
|
$
|
17,070
|
|
|
$
|
80,724
|
|
|
$
|
18,406
|
|
|
$
|
107,896
|
|
Additions
|
1,678
|
|
|
1,578
|
|
|
3,357
|
|
|
2,984
|
|
||||
Deductions (2)
|
(2,211
|
)
|
|
(28,484
|
)
|
|
(5,226
|
)
|
|
(57,062
|
)
|
||||
Balance at end of period
|
$
|
16,537
|
|
|
$
|
53,818
|
|
|
$
|
16,537
|
|
|
$
|
53,818
|
|
|
GPU
|
|
PSB
|
|
CPB
|
|
All Other
|
|
Consolidated
|
||||||||||
|
(In thousands)
|
||||||||||||||||||
Three Months Ended July 29, 2012
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenue
|
$
|
668,298
|
|
|
$
|
196,326
|
|
|
$
|
179,646
|
|
|
$
|
—
|
|
|
$
|
1,044,270
|
|
Depreciation and amortization expense
|
$
|
32,554
|
|
|
$
|
4,446
|
|
|
$
|
19,195
|
|
|
$
|
—
|
|
|
$
|
56,195
|
|
Operating income (loss)
|
$
|
162,644
|
|
|
$
|
86,838
|
|
|
$
|
(89,732
|
)
|
|
$
|
(20,127
|
)
|
|
$
|
139,623
|
|
Three Months Ended July 31, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Revenue
|
$
|
638,544
|
|
|
$
|
210,289
|
|
|
$
|
167,684
|
|
|
$
|
—
|
|
|
$
|
1,016,517
|
|
Depreciation and amortization expense
|
$
|
30,663
|
|
|
$
|
5,869
|
|
|
$
|
15,628
|
|
|
$
|
—
|
|
|
$
|
52,160
|
|
Operating income (loss)
|
$
|
139,708
|
|
|
$
|
69,863
|
|
|
$
|
(35,541
|
)
|
|
$
|
—
|
|
|
$
|
174,030
|
|
Six Months Ended July 29, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Revenue
|
$
|
1,248,019
|
|
|
$
|
408,970
|
|
|
$
|
312,158
|
|
|
$
|
—
|
|
|
$
|
1,969,147
|
|
Depreciation and amortization expense
|
$
|
64,130
|
|
|
$
|
8,831
|
|
|
$
|
37,725
|
|
|
$
|
—
|
|
|
$
|
110,686
|
|
Operating income (loss)
|
$
|
241,592
|
|
|
$
|
182,625
|
|
|
$
|
(191,641
|
)
|
|
$
|
(20,127
|
)
|
|
$
|
212,449
|
|
Six Months Ended July 31, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Revenue
|
$
|
1,276,133
|
|
|
$
|
412,130
|
|
|
$
|
290,293
|
|
|
$
|
—
|
|
|
$
|
1,978,556
|
|
Depreciation and amortization expense
|
$
|
59,691
|
|
|
$
|
11,987
|
|
|
$
|
28,245
|
|
|
$
|
—
|
|
|
$
|
99,923
|
|
Operating income (loss)
|
$
|
259,990
|
|
|
$
|
139,748
|
|
|
$
|
(70,846
|
)
|
|
$
|
—
|
|
|
$
|
328,892
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
July 29,
|
|
July 31,
|
|
July 29,
|
|
July 31,
|
||||||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
(In thousands)
|
||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
China
|
$
|
196,687
|
|
|
$
|
232,732
|
|
|
$
|
375,297
|
|
|
$
|
522,216
|
|
Taiwan
|
340,144
|
|
|
281,609
|
|
|
616,463
|
|
|
564,546
|
|
||||
Other Asia Pacific
|
212,367
|
|
|
205,524
|
|
|
391,044
|
|
|
338,111
|
|
||||
United States
|
154,814
|
|
|
153,171
|
|
|
300,756
|
|
|
262,489
|
|
||||
Other Americas
|
81,260
|
|
|
68,224
|
|
|
157,082
|
|
|
143,354
|
|
||||
Europe
|
58,998
|
|
|
75,257
|
|
|
128,505
|
|
|
147,840
|
|
||||
Total revenue
|
$
|
1,044,270
|
|
|
$
|
1,016,517
|
|
|
$
|
1,969,147
|
|
|
$
|
1,978,556
|
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
||||||
|
July 29,
2012 |
|
|
July 31,
2011 |
|
|
July 29,
2012 |
|
|
July 31,
2011 |
|
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
Cost of revenue
|
48.2
|
|
|
48.3
|
|
|
49.0
|
|
|
49.0
|
|
Gross profit
|
51.8
|
|
|
51.7
|
|
|
51.0
|
|
|
51.0
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
26.9
|
|
|
24.4
|
|
|
28.7
|
|
|
24.2
|
|
Sales, general and administrative
|
11.5
|
|
|
10.2
|
|
|
11.5
|
|
|
10.2
|
|
Total operating expenses
|
38.4
|
|
|
34.6
|
|
|
40.2
|
|
|
34.4
|
|
Operating income
|
13.4
|
|
|
17.1
|
|
|
10.8
|
|
|
16.6
|
|
Interest and other income, net
|
0.5
|
|
|
0.3
|
|
|
0.5
|
|
|
0.3
|
|
Income before income tax
|
13.9
|
|
|
17.4
|
|
|
11.3
|
|
|
16.9
|
|
Income tax expense
|
2.5
|
|
|
2.6
|
|
|
2.2
|
|
|
2.4
|
|
Net income
|
11.4
|
%
|
|
14.8
|
%
|
|
9.1
|
%
|
|
14.5
|
%
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|||||||||||||||||||||||||
|
July 29,
2012 |
|
July 31,
2011 |
|
$
Change
|
|
%
Change
|
|
|
July 29,
2012 |
|
|
July 31,
2011 |
|
$
Change
|
|
%
Change
|
|
||||||||||||
|
($ in millions)
|
|
|
|
|
($ in millions)
|
|
|
|
|||||||||||||||||||||
Research and development expenses
|
$
|
281.2
|
|
|
$
|
247.7
|
|
|
$
|
33.5
|
|
|
13.5
|
%
|
|
$
|
565.1
|
|
|
|
$
|
479.2
|
|
|
$
|
85.9
|
|
|
17.9
|
%
|
Sales, general and administrative expenses
|
119.9
|
|
|
103.5
|
|
|
16.4
|
|
|
15.8
|
%
|
|
226.5
|
|
|
|
201.7
|
|
|
24.8
|
|
|
12.3
|
%
|
||||||
Total operating expenses
|
$
|
401.1
|
|
|
$
|
351.2
|
|
|
$
|
49.9
|
|
|
14.2
|
%
|
|
$
|
791.6
|
|
|
|
$
|
680.9
|
|
|
$
|
110.7
|
|
|
16.3
|
%
|
Research and development as a percentage of net revenue
|
26.9
|
|
%
|
24.4
|
|
%
|
|
|
|
|
|
|
28.7
|
|
%
|
|
24.2
|
|
%
|
|
|
|
|
|
||||||
Sales, general and administrative as a percentage of net revenue
|
11.5
|
|
%
|
10.2
|
|
%
|
|
|
|
|
|
|
11.5
|
|
%
|
|
10.2
|
|
%
|
|
|
|
|
|
|
As of July 29, 2012
|
|
As of January 29, 2012
|
||||
|
(In millions)
|
||||||
Cash and cash equivalents
|
$
|
499.6
|
|
|
$
|
667.9
|
|
Marketable securities
|
2,778.5
|
|
|
2,461.7
|
|
||
Cash, cash equivalents, and marketable securities
|
$
|
3,278.1
|
|
|
$
|
3,129.6
|
|
|
Six Months Ended
|
||||||
|
July 29,
|
|
July 31,
|
||||
|
2012
|
|
2011
|
||||
|
(In millions)
|
||||||
Net cash provided by operating activities
|
$
|
191.7
|
|
|
$
|
254.2
|
|
Net cash used in investing activities
|
$
|
(419.8
|
)
|
|
$
|
(525.7
|
)
|
Net cash provided by financing activities
|
$
|
59.8
|
|
|
$
|
138.8
|
|
•
|
suppliers of GPUs, including chipsets that incorporate three-dimensional, or 3D, graphics functionality as part of their existing solutions, such as Advanced Micro Devices, or AMD, Intel Corporation, Matrox Electronics Systems Ltd. and VIA Technologies, Inc.;
|
•
|
suppliers of system-on-chip products that support tablets, smartphones, automotive navigation and other similar devices, such as AMD, Broadcom Corporation, Freescale Semiconductor Inc., Fujitsu Limited, Intel, Marvell Technology Group Ltd., NEC Corporation, Qualcomm Incorporated, Renesas Electronics Corporation, Samsung Electronics Co. Ltd., Seiko Epson Corporation, ST-Ericsson, Texas Instruments Incorporated and Toshiba America Electronic Components, Inc.;
|
•
|
licensors of graphics technologies, such as ARM Holdings plc and Imagination Technologies Group plc; and
|
•
|
suppliers of cellular basebands, such as Broadcom, Freescale Semiconductor, GCT Semiconductor Inc., HiSilicon Technologies Co., Ltd., Intel, Marvell, Mediatek, Qualcomm, Renesas Electronics, Samsung, Spreadtrum Communications Inc., ST-Ericsson, Texas Instruments and VIA Technologies, Inc.
|
•
|
continue to keep pace with technological developments;
|
•
|
develop and introduce new products, services, technologies and enhancements on a timely basis;
|
•
|
transition our semiconductor products to increasingly smaller line width geometries;
|
•
|
obtain sufficient foundry capacity and packaging materials; and
|
•
|
succeed in significant foreign markets, such as China and India.
|
•
|
effectively identify and capitalize upon opportunities in new markets;
|
•
|
timely complete and introduce new products and technologies;
|
•
|
transition our semiconductor products to increasingly smaller line width geometries; and
|
•
|
obtain sufficient foundry capacity and packaging materials.
|
•
|
anticipate the features and functionality that customers and consumers will demand;
|
•
|
incorporate those features and functionalities into products that meet the exacting design requirements of our customers;
|
•
|
price our products competitively; and
|
•
|
introduce products to the market within our customers' limited design cycles.
|
•
|
substantially all of our sales are made on a purchase order basis, which permits our customers to cancel, change or delay product purchase commitments with little or no notice to us and without penalty;
|
•
|
our customers may develop their own solutions;
|
•
|
our customers may purchase products from our competitors; or
|
•
|
our customers may discontinue sales or lose market share in the markets for which they purchase our products.
|
•
|
the mix of our products sold;
|
•
|
average selling prices;
|
•
|
introduction of new products;
|
•
|
product transitions;
|
•
|
sales discounts;
|
•
|
unexpected pricing actions by our competitors;
|
•
|
the cost of product components; and
|
•
|
the yield of wafers produced by the foundries that manufacture our products.
|
•
|
changes in business and economic conditions, including downturns in the semiconductor industry and/or overall economy;
|
•
|
changes in consumer confidence caused by changes in market conditions, including changes in the credit market, expectations for inflation, and energy prices;
|
•
|
if there were a sudden and significant decrease in demand for our products;
|
•
|
if there were a higher incidence of inventory obsolescence because of rapidly changing technology and customer requirements;
|
•
|
if we fail to estimate customer demand properly for our older products as our newer products are introduced; or
|
•
|
if our competition were to take unexpected competitive pricing actions.
|
•
|
difficulty in combining the technology, products, operations or workforce of the acquired business with our business;
|
•
|
difficulty in operating in a new or multiple new locations;
|
•
|
disruption of our ongoing businesses or the ongoing business of the company we invest in or acquire;
|
•
|
difficulty in realizing the potential financial or strategic benefits of the transaction;
|
•
|
difficulty in maintaining uniform standards, controls, procedures and policies;
|
•
|
difficulty integrating the target's accounting, management information, human resources and other administrative systems;
|
•
|
disruption of or delays in ongoing research and development efforts;
|
•
|
diversion of capital and other resources;
|
•
|
assumption of liabilities;
|
•
|
incurring acquisition-related costs or amortization costs for acquired intangible assets that could impact our operating results;
|
•
|
diversion of resources and unanticipated expenses resulting from litigation arising from potential or actual business acquisitions or investments;
|
•
|
potential failure of the due diligence processes to identify significant issues with product quality, architecture and development, or legal and financial contingencies, among other things;
|
•
|
difficulties in entering into new markets in which we have limited or no experience and where competitors in such markets have stronger positions;
|
•
|
incurring significant exit charges if products acquired in business combinations are unsuccessful;
|
•
|
potential inability to obtain, or obtain in a timely manner, approvals from governmental authorities, which could delay or prevent such acquisitions or investments;
|
•
|
potential delay in customer and distributor purchasing decisions due to uncertainty about the direction of our product offerings; and
|
•
|
impairment of relationships with employees, vendors and customers, or the loss of any of our key employees, vendors or customers or our target's key employees, vendors or customers, as a result of our acquisition or investment.
|
•
|
international economic and political conditions, such as political tensions between countries in which we do business;
|
•
|
unexpected changes in, or impositions of, legislative or regulatory requirements;
|
•
|
complying with a variety of foreign laws;
|
•
|
differing legal standards with respect to protection of intellectual property and employment practices;
|
•
|
local business and cultural factors that differ from our normal standards and practices, including business practices that we are prohibited from engaging in by the Foreign Corrupt Practices Act (FCPA) and other anticorruption laws and regulations;
|
•
|
inadequate local infrastructure that could result in business disruptions;
|
•
|
exporting or importing issues related to export or import restrictions, tariffs, quotas and other trade barriers and restrictions;
|
•
|
financial risks such as longer payment cycles, difficulty in collecting accounts receivable and fluctuations in currency exchange rates;
|
•
|
imposition of additional taxes and penalties;
|
•
|
increased costs due to imposition of climate change regulations, such as carbon taxes, fuel or energy taxes, and pollution limits; and
|
•
|
other factors beyond our control such as terrorism, cyber attack, civil unrest, war and diseases such as severe acute respiratory syndrome and the Avian flu.
|
•
|
the jurisdictions in which profits are determined to be earned and taxed;
|
•
|
adjustments to estimated taxes upon finalization of various tax returns;
|
•
|
changes in available tax credits;
|
•
|
changes in stock-based compensation expense;
|
•
|
changes in tax laws, the interpretation of tax laws either in the United States or abroad or the issuance of new interpretative accounting guidance related to transactions and calculations where the tax treatment was previously uncertain; and
|
•
|
the resolution of issues arising from tax audits with various tax authorities.
|
•
|
assert claims of infringement of our intellectual property;
|
•
|
enforce our patents;
|
•
|
protect our trade secrets or know-how; or
|
•
|
determine the enforceability, scope and validity of the propriety rights of others.
|
•
|
the commercial significance of our operations and our competitors' operations in particular countries and regions;
|
•
|
the location in which our products are manufactured;
|
•
|
our strategic technology or product directions in different countries; and
|
•
|
the degree to which intellectual property laws exist and are meaningfully enforced in different jurisdictions.
|
•
|
the possibility of environmental contamination and the costs associated with mitigating any environmental problems;
|
•
|
adverse changes in the value of these properties, due to interest rate changes, changes in the market in which the property is located, or other factors;
|
•
|
the risk of loss if we decide to sell and are not able to recover all capitalized costs;
|
•
|
increased cash commitments for the possible construction of a campus;
|
•
|
the possible need for structural improvements in order to comply with zoning, seismic and other legal or regulatory requirements;
|
•
|
increased operating expenses for the buildings or the property or both;
|
•
|
possible disputes with third parties, such as neighboring owners or others, related to the buildings or the property or both; and
|
•
|
the risk of financial loss in excess of amounts covered by insurance, or uninsured risks, such as the loss caused by damage to the buildings as a result of earthquakes, floods and or other natural disasters.
|
•
|
the ability of our Board to create and issue preferred stock without prior stockholder approval;
|
•
|
the prohibition of stockholder action by written consent;
|
•
|
a classified Board, which will become fully declassified from and after our 2014 Annual Meeting of Stockholders; and
|
•
|
advance notice requirements for director nominations and stockholder proposals.
|
Exhibit No.
|
|
Exhibit Description
|
|
Schedule
/Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
10.1*
|
|
Amended and Restated 2007 Equity Incentive Plan - Nonstatutory Stock Option
|
|
|
|
|
|
|
|
|
10.2*
|
|
Amended and Restated 2007 Equity Incentive Plan - Incentive Stock Option
|
|
|
|
|
|
|
|
|
10.3*
|
|
Amended and Restated 2007 Equity Incentive Plan - Restricted Stock Unit Grant Notice and Restricted Stock Unit Purchase Agreement
|
|
|
|
|
|
|
|
|
10.4
|
|
Amended and Restated 2007 Equity Incentive Plan - Non-Employee Director Restricted Stock Unit (without deferral option)
|
|
10-Q
|
|
000-23985
|
|
10.2
|
|
May 23, 2012
|
10.5
|
|
Amended and Restated 2007 Equity Incentive Plan - Non-Employee Director Restricted Stock Unit (with deferral option)
|
|
10-Q
|
|
000-23985
|
|
10.3
|
|
May 23, 2012
|
10.6
|
|
Amended and Restated 2007 Equity Incentive Plan - Non-Employee Director Stock Option Grant (2012 Annual Board Retainer)
|
|
10-Q
|
|
000-23985
|
|
10.4
|
|
May 23, 2012
|
10.7
|
|
Amended and Restated 2007 Equity Incentive Plan
|
|
10-Q
|
|
000-23985
|
|
10.5
|
|
May 23, 2012
|
10.8
|
|
2012 Employee Stock Purchase Plan
|
|
10-Q
|
|
000-23985
|
|
10.6
|
|
May 23, 2012
|
31.1*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
31.2*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.1#*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.2#*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
NVIDIA Corporation
|
||
By:
|
/s/
Karen Burns
|
|
|
|
|
|
|
|
Karen Burns
|
||
|
Interim Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)
|
Exhibit No.
|
|
Exhibit Description
|
|
Schedule
/Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
10.1*
|
|
Amended and Restated 2007 Equity Incentive Plan - Nonstatutory Stock Option
|
|
|
|
|
|
|
|
|
10.2*
|
|
Amended and Restated 2007 Equity Incentive Plan - Incentive Stock Option
|
|
|
|
|
|
|
|
|
10.3*
|
|
Amended and Restated 2007 Equity Incentive Plan - Restricted Stock Unit Grant Notice and Restricted Stock Unit Purchase Agreement
|
|
|
|
|
|
|
|
|
10.4
|
|
Amended and Restated 2007 Equity Incentive Plan - Non-Employee Director Restricted Stock Unit (without deferral option)
|
|
10-Q
|
|
000-23985
|
|
10.2
|
|
May 23, 2012
|
10.5
|
|
Amended and Restated 2007 Equity Incentive Plan - Non-Employee Director Restricted Stock Unit (with deferral option)
|
|
10-Q
|
|
000-23985
|
|
10.3
|
|
May 23, 2012
|
10.6
|
|
Amended and Restated 2007 Equity Incentive Plan - Non-Employee Director Stock Option Grant (2012 Annual Board Retainer)
|
|
10-Q
|
|
000-23985
|
|
10.4
|
|
May 23, 2012
|
10.7
|
|
Amended and Restated 2007 Equity Incentive Plan
|
|
10-Q
|
|
000-23985
|
|
10.5
|
|
May 23, 2012
|
10.8
|
|
2012 Employee Stock Purchase Plan
|
|
10-Q
|
|
000-23985
|
|
10.6
|
|
May 23, 2012
|
31.1*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
31.2*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.1#*
|
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
32.2#*
|
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|